why choose us

First received: December 20, 2022

Clinical Trial: OMAR Opioid Use Disorder

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy Control

Study Type: INTERVENTIONAL


Official Title: Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder

Brief Summary: The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.

Read more